128 related articles for article (PubMed ID: 3429944)
21. Serum neuron-specific enolase as a marker of small-cell carcinoma of the esophagus.
Sasajima K; Watanabe M; Ando T; Hao K; Miyashita M; Yamashita K; Onda M; Takubo K
J Clin Gastroenterol; 1990 Aug; 12(4):384-8. PubMed ID: 2168912
[TBL] [Abstract][Full Text] [Related]
22. Serum NSE, CEA, CT, CA 15-3 levels in human lung cancer.
Nutini S; Cappelli G; Benucci A; Catalani C; Nozzoli F
Int J Biol Markers; 1990; 5(4):198-202. PubMed ID: 1965544
[TBL] [Abstract][Full Text] [Related]
23. Neuron specific enolase (NSE) in serum of patients with malignant melanoma.
Wibe E; Paus E; Aamdal S
Cancer Lett; 1990 Jun; 52(1):29-31. PubMed ID: 2354416
[TBL] [Abstract][Full Text] [Related]
24. Serum neuron-specific enolase in diagnosis and follow-up of gastrointestinal neuroendocrine tumors.
D'Alessandro M; Mariani P; Lomanto D; Carlei F; Lezoche E; Speranza V
Tumour Biol; 1992; 13(5-6):352-7. PubMed ID: 1290031
[TBL] [Abstract][Full Text] [Related]
25. [Significance of serum neuron-specific enolase before treatment in predicting brain metastases and prognosis of advanced non-small cell lung cancer].
Chen Y; Peng W; Huang Y; Chen J; Su G; Jiang C; Xiao Y
Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):508-11. PubMed ID: 26463326
[TBL] [Abstract][Full Text] [Related]
26. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
[TBL] [Abstract][Full Text] [Related]
27. Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma.
van de Pol M; Twijnstra A; ten Velde GP; Menheere PP
J Neurooncol; 1994; 19(2):149-54. PubMed ID: 7964990
[TBL] [Abstract][Full Text] [Related]
28. Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer.
Jørgensen LG; Hansen HH; Cooper EH
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):123-8. PubMed ID: 2537729
[TBL] [Abstract][Full Text] [Related]
29. [The value of neuron specific enolase (NSE) in patients with brain tumors].
Taomoto K; Kokunai T; Okuda T; Tamaki N; Matsumoto S; Hashimoto N
No To Shinkei; 1987 Feb; 39(2):169-73. PubMed ID: 3828153
[TBL] [Abstract][Full Text] [Related]
30. Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practice.
Splinter TA; Carney DN; Teeling M; Peake MD; Kho GS; Oosterom R; Cooper EH
J Cancer Res Clin Oncol; 1989; 115(4):400-1. PubMed ID: 2547802
[TBL] [Abstract][Full Text] [Related]
31. Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers.
Gaiser MR; Daily K; Hoffmann J; Brune M; Enk A; Brownell I
Oncotarget; 2015 Sep; 6(28):26472-82. PubMed ID: 26299616
[TBL] [Abstract][Full Text] [Related]
32. Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens.
Pacini F; Basolo F; Elisei R; Fugazzola L; Cola A; Pinchera A
Am J Clin Pathol; 1991 Mar; 95(3):300-8. PubMed ID: 1996540
[TBL] [Abstract][Full Text] [Related]
33. Enolase subunits in patients with neuroendocrine tumors.
Iwase K; Nagasaka A; Kato K; Ohtani S; Nagatsu I; Ohyama T; Nakai A; Aono T; Nakagawa H; Shinoda S
J Clin Endocrinol Metab; 1986 Jul; 63(1):94-101. PubMed ID: 3519652
[TBL] [Abstract][Full Text] [Related]
34. S-100 and NSE as serum markers in melanoma.
Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL
Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097
[TBL] [Abstract][Full Text] [Related]
35. Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer.
Huang Z; Xu D; Zhang F; Ying Y; Song L
Clin Transl Oncol; 2016 Oct; 18(10):1019-25. PubMed ID: 26886220
[TBL] [Abstract][Full Text] [Related]
36. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
Taitou H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ookura H; Saijo N
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy.
Kamiya N; Akakura K; Suzuki H; Isshiki S; Komiya A; Ueda T; Ito H
Eur Urol; 2003 Sep; 44(3):309-14; discussion 314. PubMed ID: 12932928
[TBL] [Abstract][Full Text] [Related]
38. Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma.
Lloyd RV; Sisson JC; Marangos PJ
Cancer; 1983 Jun; 51(12):2234-9. PubMed ID: 6342746
[TBL] [Abstract][Full Text] [Related]
39. [A case of malignant pheochromocytoma with high levels of serum neuron-specific enolase (NSE) and calcitonin].
Ikeda I; Okuno T; Terao T; Masuda M; Hirokawa M
Hinyokika Kiyo; 1994 Sep; 40(9):813-6. PubMed ID: 7801842
[TBL] [Abstract][Full Text] [Related]
40. Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
Harding M; McAllister J; Hulks G; Vernon D; Monie R; Paul J; Kaye SB
Br J Cancer; 1990 Apr; 61(4):605-7. PubMed ID: 2158809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
